How Long Does It Take for Wegovy or Ozempic to Start Working?
One of the most common questions from people starting a GLP-1 medication is: how long until I actually see results? The short answer is that you may notice some effects — particularly reduced appetite — within the first few weeks. But meaningful, visible weight loss typically takes longer, and the full effect of the medication isn't felt until you've been at maintenance dose for several months.
Here's a realistic timeline.
Week by Week: What to Expect
Weeks 1–4: The 0.25mg Starting Dose
The starting dose is a tolerance-building dose, not a therapeutic one. Some people notice mild nausea or GI discomfort. A few notice a slight reduction in appetite. Most notice nothing obvious on the scale. This is expected — the medication needs time to reach steady levels in your system and the starting dose is intentionally low.
Weeks 5–8: First Therapeutic Dose
At 0.5mg, most people begin to notice genuine appetite suppression — meals feel more satisfying, and it's easier to stop eating before feeling overfull. For some, food noise (the constant background mental chatter about food) noticeably quiets. Weight loss often begins here, though it may be slow and not yet obvious to others.
Weeks 9–16: Escalation Phase
As you move through 1.0mg and 1.7mg, appetite suppression becomes more pronounced and consistent. Weight loss accelerates for most people. The first noticeable changes in body composition often become visible to both you and others in this window — particularly for people who started with a higher body weight.
Week 17 Onward: Maintenance Dose
At 2.4mg, the medication is at its full therapeutic level. This is where the majority of long-term weight loss occurs. The STEP 1 trial ran for 68 weeks — participants were still losing weight at week 68, having been at maintenance dose since roughly week 17. Expect weight loss to continue at a moderate, sustained rate for many months.
Why the First Weeks Can Feel Discouraging
The gap between starting the medication and seeing visible results is the most common reason people second-guess their decision. The first four weeks produce little visible effect. The next four produce modest results. By the time you've been on the medication for three months, you may have lost 3–5kg if you're responding well — which is real progress, but might not feel dramatic after three months of weekly injections.
This is where a tracking chart helps enormously. A 3kg loss in 12 weeks is 0.25kg per week — slow by the standards of dramatic social media transformations, but consistent with clinical trial data and meaningful for long-term health. Seeing that trajectory on a chart, rather than just comparing today's weight to last week's, puts the pace in perspective.
Why Some People See Results Faster Than Others
Individual response to GLP-1 medications varies significantly. People who see early results tend to share some characteristics: they eat primarily whole foods and can easily reduce portion sizes; they're physically active; and they respond strongly to the appetite-suppressing effect from early doses.
People who see slower early results often find the medication's full effect only kicks in at higher doses, or find that their eating patterns need more deliberate adjustment alongside the medication. That doesn't mean the medication won't work for them — it often means the results come later and then continue longer.
The "Food Noise" Effect
One of the most striking effects of GLP-1 medications that isn't captured by a number on the scale is the reduction in what many people describe as "food noise" — the constant mental preoccupation with food, what to eat next, when to eat, craving management. This effect appears quickly for many people, often within the first few weeks at even low doses.
For people who have spent years managing their weight through willpower and dietary discipline, the reduction in food noise can feel profound — almost like a different experience of appetite. Weight loss follows from this change in the background hum of hunger, but the subjective experience often precedes the numbers on the scale.
Plateaus: Normal, and Not the End
Even on GLP-1 medications, weight loss plateaus are common. The body adapts to a lower calorie intake over time, and weight loss naturally slows as you get closer to your goal. A plateau of two to four weeks on the scale is normal and shouldn't be interpreted as the medication stopping. The most common reason weight loss stalls is that your calorie intake has crept back up as the appetite-suppressing effect feels more familiar. Checking in on what and how much you're eating during a plateau is usually more productive than assuming the medication has stopped working.
Track week by week and see your trajectory
The GLP-1 HQ tracker shows your weight trend over time alongside your injection history and weeks on medication. Log your weight weekly and the chart does the rest — so you can see progress even when individual weeks feel flat.
Start tracking →What About Mounjaro and Zepbound?
Tirzepatide (Mounjaro/Zepbound) follows a similar timeline, with escalation from 2.5mg through to 15mg over approximately 20 weeks. The appetite-suppressing effect is generally described as appearing quickly — sometimes within the first two weeks — and the weight loss results at the maximum dose exceed those seen with semaglutide in the trial data. The timeline to full effect is comparable: expect to be at maintenance dose for several months before seeing the bulk of your results.
Whether you're on semaglutide or tirzepatide, the core message is the same: patience and consistency matter more than quick results. These medications work over months, not weeks. The people who see the best long-term outcomes are almost always those who give the medication the full time it needs to work.
Medical disclaimer: Individual responses to GLP-1 medications vary. The timelines described in this article are general guides based on clinical trial data and typical patient experience, not a guarantee of any individual's results. Consult your prescriber if you have concerns about your response to medication.